Surgical Forceps Market Synopsis

Surgical Forceps Market Size Was Valued at USD 35.80 Billion in 2023, and is Projected to Reach USD 54.53 Billion by 2032, Growing at a CAGR of 5.4% From 2024-2032.

An instrument for grasping, holding firmly, or exerting traction upon objects, especially for delicate operations (as by surgeons, obstetricians, or dentists). A wide range of medical treatments involve the utilization of forceps, and the healthcare industry has demonstrated an impressive amount of zeal in its efforts to combat the growing incidence of chronic diseases. Additionally, the medical industry has shown evidence of innovation by introducing a variety of cutting-edge pieces of equipment, such as surgical forceps. The utilization of surgical forceps is essential to the operation of a variety of different kinds of equipment and tools. They come in handy when one needs to hold a lot of things at once or when one's fingers are too large to properly grasp smaller items.

• Advancements in medical technology have led to the development of more precise and specialized surgical instruments, including forceps, which enhance surgical outcomes and minimize patient trauma. These advancements have increased the demand for surgical forceps among healthcare professionals.
• An aging global population is driving the prevalence of chronic diseases and the need for surgical interventions. As a result, there's a rising number of surgical procedures performed worldwide, boosting the demand for surgical instruments such as forceps.
• Furthermore, rising awareness among healthcare providers regarding the importance of maintaining sterile and high-quality surgical instruments to prevent infections and complications is also propelling market growth. Manufacturers are thus innovating to produce forceps that are durable, easy to clean, and maintain sterility throughout surgical procedures, catering to the evolving needs of the healthcare sector.

Surgical Forceps Market Trend Analysis

Growing Interest in Domestic Aquariums

• Advancements in materials and manufacturing technologies have enabled the production of forceps with enhanced durability, precision, and ergonomic designs. Materials such as stainless-steel alloys and titanium alloys offer superior strength and resistance to corrosion, ensuring longevity and reliability in surgical settings. Additionally, innovations in machining processes, such as CNC (Computer Numerical Control) machining, allow for intricate designs and precise tolerances, resulting in high-quality forceps with consistent performance.
• There is a growing emphasis on patient safety and surgical outcomes, driving demand for surgical instruments that minimize tissue trauma and improve surgical precision. High-quality forceps with finer tips and smoother grasping surfaces enable surgeons to perform delicate maneuvers with greater control, reducing the risk of tissue damage and post-operative complications. Moreover, ergonomic designs reduce hand fatigue and improve surgeon comfort during prolonged procedures, enhancing overall procedural efficiency and patient care.
• Moreover, the rising prevalence of minimally invasive surgical techniques, such as laparoscopy and robotic-assisted surgery, has spurred the demand for specialized forceps optimized for these procedures. Miniaturized forceps with articulating tips and advanced gripping mechanisms enable precise manipulation of tissues through small incisions, expanding the applicability of minimally invasive approaches across various surgical specialties.

The Increasing Preference for Captive-Bred Clownfish

• advanced designs in surgical forceps prioritize ergonomics to improve surgeon comfort and precision during procedures. These forceps are engineered with considerations for grip comfort, weight distribution, and maneuverability, reducing fatigue and enhancing dexterity. By minimizing surgeon strain and fatigue, these designs contribute to more consistent performance and potentially reduce the risk of procedural errors.
• Moreover, the integration of safety features within surgical forceps addresses critical concerns regarding patient welfare and procedural accuracy. These features include mechanisms such as locking systems to secure tissue grasp, preventing accidental slippage or damage. Additionally, innovations like insulation coatings mitigate the risk of unintended tissue burns or trauma, particularly in delicate procedures involving electrosurgical techniques. Such safety measures not only safeguard patient well-being but also instill confidence in surgeons, promoting smoother procedural workflows.
• Furthermore, advanced designs and safety features foster versatility and adaptability in surgical forceps, catering to diverse procedural requirements across various medical specialties. For instance, specialized forceps with interchangeable tips or adjustable tension mechanisms accommodate varying tissue types and surgical techniques, ensuring optimal performance across different clinical scenarios. This adaptability enhances surgical precision and efficiency, contributing to superior patient outcomes and reduced recovery times.

Surgical Forceps Market Segment Analysis:

Surgical Forceps Market is Segmented on the basis of product, end users.

By Product, Fine Artery Forceps segment is expected to dominate the market during the forecast period

• The Fine Artery Forceps segment within the Surgical Forceps Market is experiencing growth due to several key factors. Advancements in surgical techniques and procedures require precision instruments, driving the demand for fine artery forceps which offer delicate handling and manipulation of tissues and vessels.
• Additionally, as surgeries become increasingly minimally invasive, there's a growing need for specialized instruments like fine artery forceps that can access and manipulate small structures with precision.
• Moreover, the rising incidence of chronic diseases such as cardiovascular conditions necessitates more intricate surgeries, further fueling the demand for fine artery forceps. Additionally, an aging population globally contributes to increased surgical interventions, especially in areas like cardiac and vascular surgeries, where fine artery forceps are indispensable tools.

By End Users, General Surgery segment held the largest share of 45.2% in 2023

• Advancements in surgical techniques and technology have led to an increase in various types of general surgeries worldwide, including procedures related to gastrointestinal, abdominal, and thoracic surgeries. These surgeries often require the use of forceps for grasping, holding, or manipulating tissues and organs with precision, driving the demand for surgical forceps.
• The rising prevalence of chronic diseases such as obesity, cardiovascular diseases, and cancer necessitates surgical interventions, further bolstering the demand for surgical instruments like forceps in general surgery.
• Additionally, demographic trends such as an aging population contribute to the growing demand for surgical procedures, as older individuals tend to require more medical interventions, including surgeries.

Surgical Forceps Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• The North America region segment of the Surgical Forceps Market is experiencing growth due to several factors. There's a rising demand for surgical procedures in the region, driven by an aging population requiring more medical interventions and advancements in healthcare infrastructure. Technological advancements in surgical instruments, including forceps, are increasing efficiency and precision during surgeries, thereby boosting their adoption among healthcare providers in North America.
• Moreover, stringent regulatory standards ensure the quality and safety of surgical instruments in the region, fostering trust among both healthcare professionals and patients. Additionally, increasing healthcare expenditure and insurance coverage contribute to the accessibility of surgical procedures, further propelling market growth.

Active Key Players in the Surgical Forceps Market

• B. Braun (Germany)
• Johnson & Johnson (United States)
• Medtronic (Ireland)
• Stryker Corporation (United States)
• Boston Scientific Corporation (United States)
• Olympus Corporation (Japan)
• Karl Storz GmbH & Co. KG (Germany)
• Intuitive Surgical, Inc. (United States)
• Smith & Nephew plc (United Kingdom)
• CONMED Corporation (United States)
• Cook Medical (United States)
• Zimmer Biomet Holdings, Inc. (United States)
• Becton, Dickinson and Company (United States)
• Teleflex Incorporated (United States)
• Edwards Lifesciences Corporation (United States)
• Terumo Corporation (Japan)
• Hoya Corporation (Japan)
• Abbott Laboratories (United States)
• Essilor International (France)
• Getinge AB (Sweden)
• Merit Medical Systems, Inc. (United States)
• Mölnlycke Health Care (Sweden)
• DJO Global, Inc. (United States)
• AngioDynamics, Inc. (United States)
• Nipro Corporation (Japan), and Other Major Players.

Key Industry Development in The Surgical Forceps Market

• In December 2023, Carl Zeiss Meditec AG announced the acquisition of Dutch Ophthalmic Research Center (D.O.R.C.). D.O.R.C. is a leader in retinal surgical devices, a specific type of surgical forceps. This acquisition strengthens Carl Zeiss Meditec's position in ophthalmic technologies and caters to the growing demand for minimally invasive procedures.
• In June 2022, Ethicon, a Johnson & Johnson MedTech division, launched the ECHELON 3000 Stapler in the United States. It is a digitally enabled device that allows surgeons to address the unique needs of their patients with simple, one-handed powered articulation.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. SURGICAL FORCEPS MARKET BY PRODUCT (2017-2030)
   1. SURGICAL FORCEPS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HEMOSTATIC
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017-2030F)
      3. Historic And Forecasted Market Size in Volume (2017-2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. THUMB FORCEPS
   5. FINE ARTERY FORCEPS
   6. OTHERS
7. SURGICAL FORCEPS MARKET BY END-USER (2017-2030)
   1. SURGICAL FORCEPS MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. GYNECOLOGY
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017-2030F)
      3. Historic And Forecasted Market Size in Volume (2017-2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. GENERAL SURGERY
   5. NEURO SURGERY
   6. PLASTIC SURGERY
   7. OTHERS
8. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Benchmarking
      2. Surgical Forceps Market Share By Manufacturer (2023)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. B. BRAUN (GERMANY)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. JOHNSON & JOHNSON (UNITED STATES)
   4. MEDTRONIC (IRELAND)
   5. STRYKER CORPORATION (UNITED STATES)
   6. BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
   7. OLYMPUS CORPORATION (JAPAN)
   8. KARL STORZ GMBH & CO. KG (GERMANY)
   9. INTUITIVE SURGICAL, INC. (UNITED STATES)
   10. SMITH & NEPHEW PLC (UNITED KINGDOM)
   11. CONMED CORPORATION (UNITED STATES)
   12. COOK MEDICAL (UNITED STATES)
   13. ZIMMER BIOMET HOLDINGS, INC. (UNITED STATES)
   14. BECTON, DICKINSON AND COMPANY (UNITED STATES)
   15. TELEFLEX INCORPORATED (UNITED STATES)
   16. EDWARDS LIFESCIENCES CORPORATION (UNITED STATES)
   17. TERUMO CORPORATION (JAPAN)
   18. HOYA CORPORATION (JAPAN)
   19. ABBOTT LABORATORIES (UNITED STATES)
   20. ESSILOR INTERNATIONAL (FRANCE)
   21. GETINGE AB (SWEDEN)
   22. MERIT MEDICAL SYSTEMS, INC. (UNITED STATES)
   23. MÖLNLYCKE HEALTH CARE (SWEDEN)
   24. DJO GLOBAL, INC. (UNITED STATES)
   25. ANGIODYNAMICS, INC. (UNITED STATES)
   26. NIPRO CORPORATION (JAPAN)
9. GLOBAL SURGICAL FORCEPS MARKET BY REGION
   1. OVERVIEW
   2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Product
      4. Historic And Forecasted Market Size By End Users
      5. Historic And Forecasted Market Size By Country
         1. USA
         2. Canada
         3. Mexico
   3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Russia
         2. Bulgaria
         3. The Czech Republic
         4. Hungary
         5. Poland
         6. Romania
         7. Rest Of Eastern Europe
   4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Germany
         2. United Kingdom
         3. France
         4. The Netherlands
         5. Italy
         6. Spain
         7. Rest Of Western Europe
   5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Malaysia
         6. Thailand
         7. Vietnam
         8. The Philippines
         9. Australia
         10. New-Zealand
         11. Rest Of APAC
   6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Turkey
         2. Bahrain
         3. Kuwait
         4. Saudi Arabia
         5. Qatar
         6. UAE
         7. Israel
         8. South Africa
   7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Brazil
         2. Argentina
         3. Rest of South America
10. INVESTMENT ANALYSIS
11. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SURGICAL FORCEPS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SURGICAL FORCEPS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SURGICAL FORCEPS MARKET COMPETITIVE RIVALRY
TABLE 005. SURGICAL FORCEPS MARKET THREAT OF NEW ENTRANTS
TABLE 006. SURGICAL FORCEPS MARKET THREAT OF SUBSTITUTES
TABLE 007. SURGICAL FORCEPS MARKET BY PRODUCT TYPE
TABLE 008. HEMOSTATIC MARKET OVERVIEW (2016-2028)
TABLE 009. THUMB FORCEPS MARKET OVERVIEW (2016-2028)
TABLE 010. FINE ARTERY FORCEPS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. SURGICAL FORCEPS MARKET BY END-USER
TABLE 013. GYNECOLOGY MARKET OVERVIEW (2016-2028)
TABLE 014. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
TABLE 015. NEUROSURGERY MARKET OVERVIEW (2016-2028)
TABLE 016. PLASTIC SURGERY MARKET OVERVIEW (2016-2028)
TABLE 017. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 018. NORTH AMERICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 019. NORTH AMERICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 020. N SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 021. EUROPE SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 022. EUROPE SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 023. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 024. ASIA PACIFIC SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 025. ASIA PACIFIC SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 026. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 027. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 028. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 029. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 030. SOUTH AMERICA SURGICAL FORCEPS MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 031. SOUTH AMERICA SURGICAL FORCEPS MARKET, BY END-USER (2016-2028)
TABLE 032. SURGICAL FORCEPS MARKET, BY COUNTRY (2016-2028)
TABLE 033. MEDGYN PRODUCTS (UNITED STATES): SNAPSHOT
TABLE 034. MEDGYN PRODUCTS (UNITED STATES): BUSINESS PERFORMANCE
TABLE 035. MEDGYN PRODUCTS (UNITED STATES): PRODUCT PORTFOLIO
TABLE 036. MEDGYN PRODUCTS (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 036. DELACROIX CHEVALIER (EUROPE): SNAPSHOT
TABLE 037. DELACROIX CHEVALIER (EUROPE): BUSINESS PERFORMANCE
TABLE 038. DELACROIX CHEVALIER (EUROPE): PRODUCT PORTFOLIO
TABLE 039. DELACROIX CHEVALIER (EUROPE): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 039. SHANGHAI MEDICAL INSTRUMENTS (CHINA): SNAPSHOT
TABLE 040. SHANGHAI MEDICAL INSTRUMENTS (CHINA): BUSINESS PERFORMANCE
TABLE 041. SHANGHAI MEDICAL INSTRUMENTS (CHINA): PRODUCT PORTFOLIO
TABLE 042. SHANGHAI MEDICAL INSTRUMENTS (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 042. MEDLINE (UNITED STATES): SNAPSHOT
TABLE 043. MEDLINE (UNITED STATES): BUSINESS PERFORMANCE
TABLE 044. MEDLINE (UNITED STATES): PRODUCT PORTFOLIO
TABLE 045. MEDLINE (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. B. BRAUN (GERMANY): SNAPSHOT
TABLE 046. B. BRAUN (GERMANY): BUSINESS PERFORMANCE
TABLE 047. B. BRAUN (GERMANY): PRODUCT PORTFOLIO
TABLE 048. B. BRAUN (GERMANY): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. SKLAR (UNITED STATES): SNAPSHOT
TABLE 049. SKLAR (UNITED STATES): BUSINESS PERFORMANCE
TABLE 050. SKLAR (UNITED STATES): PRODUCT PORTFOLIO
TABLE 051. SKLAR (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. XINHUA SURGICAL (CHINA): SNAPSHOT
TABLE 052. XINHUA SURGICAL (CHINA): BUSINESS PERFORMANCE
TABLE 053. XINHUA SURGICAL (CHINA): PRODUCT PORTFOLIO
TABLE 054. XINHUA SURGICAL (CHINA): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. HU-FRIEDY (UNITED STATES): SNAPSHOT
TABLE 055. HU-FRIEDY (UNITED STATES): BUSINESS PERFORMANCE
TABLE 056. HU-FRIEDY (UNITED STATES): PRODUCT PORTFOLIO
TABLE 057. HU-FRIEDY (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. TELEFLEX MEDICAL (UNITED STATES): SNAPSHOT
TABLE 058. TELEFLEX MEDICAL (UNITED STATES): BUSINESS PERFORMANCE
TABLE 059. TELEFLEX MEDICAL (UNITED STATES): PRODUCT PORTFOLIO
TABLE 060. TELEFLEX MEDICAL (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. J AND J INSTRUMENTS (UNITED STATES): SNAPSHOT
TABLE 061. J AND J INSTRUMENTS (UNITED STATES): BUSINESS PERFORMANCE
TABLE 062. J AND J INSTRUMENTS (UNITED STATES): PRODUCT PORTFOLIO
TABLE 063. J AND J INSTRUMENTS (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. TED PELLA (UNITED STATES): SNAPSHOT
TABLE 064. TED PELLA (UNITED STATES): BUSINESS PERFORMANCE
TABLE 065. TED PELLA (UNITED STATES): PRODUCT PORTFOLIO
TABLE 066. TED PELLA (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. SCANLAN INTERNATIONAL (UNITED STATES): SNAPSHOT
TABLE 067. SCANLAN INTERNATIONAL (UNITED STATES): BUSINESS PERFORMANCE
TABLE 068. SCANLAN INTERNATIONAL (UNITED STATES): PRODUCT PORTFOLIO
TABLE 069. SCANLAN INTERNATIONAL (UNITED STATES): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 070. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 071. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 072. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SURGICAL FORCEPS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SURGICAL FORCEPS MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. HEMOSTATIC MARKET OVERVIEW (2016-2028)
FIGURE 013. THUMB FORCEPS MARKET OVERVIEW (2016-2028)
FIGURE 014. FINE ARTERY FORCEPS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. SURGICAL FORCEPS MARKET OVERVIEW BY END-USER
FIGURE 017. GYNECOLOGY MARKET OVERVIEW (2016-2028)
FIGURE 018. GENERAL SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 019. NEUROSURGERY MARKET OVERVIEW (2016-2028)
FIGURE 020. PLASTIC SURGERY MARKET OVERVIEW (2016-2028)
FIGURE 021. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 022. NORTH AMERICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. EUROPE SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. ASIA PACIFIC SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. MIDDLE EAST & AFRICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 026. SOUTH AMERICA SURGICAL FORCEPS MARKET OVERVIEW BY COUNTRY (2016-2028)